Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis
Status:
Completed
Trial end date:
2017-08-10
Target enrollment:
Participant gender:
Summary
This phase II pilot trial studies how well ruxolitinib phosphate and danazol work in treating
anemia in patients with myelofibrosis. Ruxolitinib phosphate and danazol may cause the body
to make more red blood cells. They are used to treat anemia in patients with myelofibrosis.